Yunli Yu

965 total citations
37 papers, 738 citations indexed

About

Yunli Yu is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Yunli Yu has authored 37 papers receiving a total of 738 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Surgery. Recurrent topics in Yunli Yu's work include Drug Transport and Resistance Mechanisms (6 papers), Berberine and alkaloids research (4 papers) and Pharmacological Effects and Toxicity Studies (4 papers). Yunli Yu is often cited by papers focused on Drug Transport and Resistance Mechanisms (6 papers), Berberine and alkaloids research (4 papers) and Pharmacological Effects and Toxicity Studies (4 papers). Yunli Yu collaborates with scholars based in China, United Kingdom and United States. Yunli Yu's co-authors include Lin Xie, Xiaodong Liu, Xinting Wang, Guangji Wang, Li Liu, Gang Hao, Cunjin Su, Xiang Liu, Aiming Shi and Can Liu and has published in prestigious journals such as Scientific Reports, Biochemical Pharmacology and Journal of Ethnopharmacology.

In The Last Decade

Yunli Yu

33 papers receiving 726 citations

Peers

Countries citing papers authored by Yunli Yu

Since Specialization

Citations

This map shows the geographic impact of Yunli Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunli Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunli Yu more than expected).

Fields of papers citing papers by Yunli Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yunli Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunli Yu. The network helps show where Yunli Yu may publish in the future.

Co-authorship network of co-authors of Yunli Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Yunli Yu. A scholar is included among the top collaborators of Yunli Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yunli Yu. Yunli Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Population pharmacokinetics and pharmacodynamics of meropenem in critically ill patients with renal impairment or on continuous renal replacement therapy 2025 ·European Journal of Clinical Pharmacology ·Feng Chen, (unknown), Yuchen Qu, Yunli Yu, (unknown), Xin Du, (unknown), Guanjun Wang, (unknown), (unknown), Jie Pan	0
2	Structure-based design and screening of hydrogel copolymer/Fe3O4 composite microspheres for magnetic solid phase extraction of bisphenol A from aqueous samples 2024 ·Talanta ·(unknown), Yunli Yu, (unknown), (unknown), Weicheng Tang, Wenfeng Tan, Mingming Liu	2
3	Evaluation of Drug–Drug Interactions Between Clarithromycin and Direct Oral Anticoagulants Using Physiologically Based Pharmacokinetic Models 2024 ·Pharmaceutics ·(unknown), Yuchen Qu, (unknown), (unknown), Tong Zhou, Yunli Yu	0
4	Systematic review and model-based analysis to identify whether renal safety risks of URAT1 inhibitors are fully determined by uric acid-lowering efficacies 2023 ·Seminars in Arthritis and Rheumatism ·Yuchen Qu, Yunli Yu, (unknown), Haiyan Li, Cheng Cui, Dongyang Liu	4
5	Gut Microbial Characteristics of Adult Patients With Epilepsy 2022 ·Frontiers in Neuroscience ·(unknown), Qian Zheng, Yongran Cheng, Mengyun Zhou, Mingwei Wang, Jianwei Xu, Zucai Xu, Guofeng Wu, Yunli Yu, Lan Ye, Zhanhui Feng	32
6	Gut Microbiota-Mediated Elevated Production of Secondary Bile Acids in Chronic Unpredictable Mild Stress 2022 ·Frontiers in Pharmacology ·Yuchen Qu, Cunjin Su, (unknown), Aiming Shi, (unknown), (unknown), (unknown), Zheng Xiang, (unknown), (unknown), (unknown), Yunli Yu	31
7	The expression profiles of circular RNAs and competing endogenous RNA networks in intrahepatic cholangiocarcinoma 2022 ·Frontiers in Cell and Developmental Biology ·Zi Liang, Liyan Liu, Xinyi Guo, (unknown), Yunli Yu, (unknown), Xiaolong Hu, Xing Zhang, Ji Wang	2
8	Posterior reversible encephalopathy syndrome with a special focus on seizures 2021 ·Journal of Clinical Neuroscience ·Xin Chen, (unknown), Bo Gao, Hui Yu, Yunli Yu, (unknown), Alexander M. McKinney	1
9	Thioredoxin-Interacting Protein (TXNIP) Regulates Parkin/PINK1-mediated Mitophagy in Dopaminergic Neurons Under High-glucose Conditions: Implications for Molecular Links Between Parkinson’s Disease and Diabetes 2020 ·Neuroscience Bulletin ·Cunjin Su, (unknown), (unknown), Ya Huang, (unknown), (unknown), Jie Pan, Aiming Shi, Tong Liu, Yunli Yu	46
10	Case of Childhood Absence Epilepsy with Focal Spikes 2019 ·World Neurosurgery ·Yunli Yu, (unknown), (unknown)	3
11	Thioredoxin‐interacting protein induced α‐synuclein accumulation via inhibition of autophagic flux: Implications for Parkinson's disease 2017 ·CNS Neuroscience & Therapeutics ·Cunjin Su, Yu Feng, (unknown), (unknown), Xu Liu, Junjie Bao, Aiming Shi, Duanmin Hu, Tong Liu, Yunli Yu	49
12	Berberine induces GLP-1 secretion through activation of bitter taste receptor pathways 2015 ·Biochemical Pharmacology ·Yunli Yu, Gang Hao, (unknown), Wenyan Hua, Meng Wang, Wenjia Zhou, (unknown), Mingxin Huang, (unknown)	88
13	Population pharmacokinetic modeling of oxcarbazepine active metabolite in Chinese patients with epilepsy 2015 ·European Journal of Drug Metabolism and Pharmacokinetics ·Yunli Yu, (unknown), Wenjun Xu, (unknown), Gang Hao	9
14	Protective effects of berberine against doxorubicin-induced cardiotoxicity in rats by inhibiting metabolism of doxorubicin 2015 ·Xenobiotica ·Gang Hao, Yunli Yu, (unknown), (unknown), (unknown)	40
15	Increased Levels of Fatty Acids Contributed to Induction of Hepatic CYP3A4 Activity Induced by Diabetes — In Vitro Evidence From HepG2 Cell and Fa2N-4 Cell Lines 2014 ·Journal of Pharmacological Sciences ·Nan Hu, Mengyue Hu, (unknown), Can Liu, (unknown), Mian Zhang, Yunli Yu, Xinting Wang, Li Liu, Xiaodong Liu	25
16	Combined contributions of over-secreted glucagon-like peptide 1 and suppressed insulin secretion to hyperglycemia induced by gatifloxacin in rats 2012 ·Toxicology and Applied Pharmacology ·Yunli Yu, Xinting Wang, Can Liu, Dan Yao, Mengyue Hu, Jia Li, Nan Hu, Li Liu, Xiaodong Liu	5
17	Verapamil exerts biphasic modulation on phenobarbital transport across the blood–brain barrier: evidence from an in vivo and in vitro study 2011 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Dan Yao, Zhihong Yang, Li Liu, Jia Li, Yunli Yu, Lulu Zhang, Xian Pan, Xiaodong Liu, Lin Xie, Guangji Wang	6
18	Increased Plasma Exposures of Five Protoberberine Alkaloids from Coptidis Rhizoma in Streptozotocin-Induced Diabetic Rats: Is P‐GP Involved? 2010 ·Planta Medica ·(unknown), Yunli Yu, Li Liu, Xinting Wang, (unknown), (unknown), Xiaodong Liu, Lin Xie, Guangji Wang	43
19	Huang-Lian-Jie-Du-Decoction modulates glucagon-like peptide-1 secretion in diabetic rats 2009 ·Journal of Ethnopharmacology ·Yunli Yu, (unknown), (unknown), Yu-Chun Liu, Ping Wang, Lin Xie, Guangji Wang, Xiaodong Liu	34
20	Modulation of glucagon-like peptide-1 release by berberine: In vivo and in vitro studies 2009 ·Biochemical Pharmacology ·Yunli Yu, Li Liu, Xinting Wang, Xiang Liu, (unknown), (unknown), Lin Xie, Guangji Wang	104

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact